Stock Analysis on Net
Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

Try for free

Gilead Sciences Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Gilead Sciences Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Accounts payable
Accrued rebates
Current portion of long-term debt, net
Other current liabilities
Current liabilities
Long-term debt, net, excluding current portion
Long-term income taxes payable
Deferred tax liability
Other long-term obligations
Long-term liabilities
Total liabilities
Preferred stock, par value $0.001 per share; none outstanding
Common stock, par value $0.001 per share
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Total Gilead stockholders’ equity
Noncontrolling interest
Total stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

The balance sheet exhibits a systemic reduction in total liabilities and a concurrent strengthening of stockholders' equity over the analyzed period. Total liabilities and stockholders' equity decreased from 67,492 million US dollars in March 2021 to 56,278 million US dollars by March 2026, indicating a contraction in the overall scale of the balance sheet primarily driven by the aggressive reduction of long-term obligations.

Liability Structure and Trends
Total liabilities followed a downward trajectory, declining from 48,528 million US dollars to 32,847 million US dollars. This reduction is largely attributable to the decrease in long-term liabilities, which fell from 38,823 million US dollars to 23,371 million US dollars. A significant portion of this decline is linked to the reduction in long-term debt, net, which decreased from 27,907 million US dollars to 20,861 million US dollars. Furthermore, long-term income taxes payable and deferred tax liabilities saw substantial decreases, with the former falling from 5,022 million US dollars to 918 million US dollars and the latter from 4,464 million US dollars to 392 million US dollars.
Current liabilities displayed more volatility, peaking at 13,964 million US dollars in June 2023 before settling at 9,476 million US dollars by March 2026. Accrued rebates showed a general upward trend, increasing from 3,369 million US dollars in March 2021 to 4,118 million US dollars in March 2026. The current portion of long-term debt experienced sharp fluctuations, notably spiking in June 2023 and March 2024, suggesting periodic refinancing or scheduled repayment cycles.
Stockholders' Equity Analysis
Total stockholders' equity increased from 18,964 million US dollars to 23,431 million US dollars over the period. A primary driver of this growth was the steady increase in additional paid-in capital, which rose consistently from 4,092 million US dollars to 9,305 million US dollars, indicating significant capital infusions. Retained earnings exhibited a more non-linear pattern; after reaching a peak of 16,304 million US dollars in December 2023, a sharp decline to 10,656 million US dollars occurred by March 2024, followed by a recovery to 14,131 million US dollars by March 2026. This volatility suggests substantial distributions of earnings or strategic capital reallocations during the 2024 fiscal period.

The overall shift in the capital structure indicates a move toward lower leverage. The simultaneous reduction in total debt and the increase in contributed capital and retained earnings suggest an improved solvency profile and a reduced reliance on external borrowing to fund operations and growth.